Announced details
Sales strategy, logistics strategy, solutions strategy, and important business issues across the Group in the wholesale business for prescription pharmaceuticals and other products
アルフレッサ株式会社 is a subsidiary of the Company. The other companies are also listed as Group companies participating in the committee.
アルフレッサ株式会社 is based in Chiyoda-ku, Tokyo, and its representative director and president is Fukujin Yusuke (福神 雄介). The other companies are listed as committee members involved in the Group's wholesale business for prescription pharmaceuticals and other products, but details such as their locations, capitalisation and year of establishment are not disclosed.
Chiyoda-ku, Tokyo (head office of アルフレッサ株式会社)
No information was provided on the impact on business performance.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Wholesale business for prescription pharmaceuticals and other products |
| Counterparty | アルフレッサ株式会社, 四国アルフレッサ株式会社, ティーエスアルフレッサ株式会社, 明祥株式会社, 株式会社琉薬, 東北アルフレッサ株式会社, 株式会社宮崎温仙堂商店 |
| Counterparty overview | アルフレッサ株式会社 is based in Chiyoda-ku, Tokyo, and its representative director and president is Fukujin Yusuke (福神 雄介). The other companies are listed as committee members involved in the Group's wholesale business for prescription pharmaceuticals and other products, but details such as their locations, capitalisation and year of establishment are not disclosed. |
| Relationship with the Company | アルフレッサ株式会社 is a subsidiary of the Company. The other companies are also listed as Group companies participating in the committee. |
| Launch date | 1 October 2026 (scheduled; date of the committee name change and scope expansion) |
| Applicable area | Sales strategy, logistics strategy, solutions strategy, and important business issues across the Group in the wholesale business for prescription pharmaceuticals and other products |
| Location | Chiyoda-ku, Tokyo (head office of アルフレッサ株式会社) |
| Impact on Business Performance | No information was provided on the impact on business performance. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The importance of addressing issues across the Group has increased, including improving logistics efficiency, providing solutions tailored to customer needs, and optimising the business operating platform.